The ROE (Return on Equity) of Karo Pharma AB (KARO.ST) is -0.30%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2021-12-31 | -0.30% |
| 2020-12-31 | 1.46% |
| 2019-12-31 | 0.16% |
| 2018-12-31 | 18.21% |
| 2017-12-31 | 0.91% |
| 2016-12-31 | 13.33% |
| 2015-12-31 | -21.36% |
| 2014-12-31 | -144.92% |
| 2013-12-31 | -92.86% |
| 2012-12-31 | -214.16% |